Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...

The phase 3 trial success over Lilly’s Trulicity (dulaglutide), an already-marketed GLP-1 class rival, further bolsters semaglutide's profile ahead of its anticipated approval later this year as ...

New Africa – stock.adobe.com In one of the two new studies, published in JAMA Neurology, researchers looked at how GLP-1 receptor agonists — drugs like semaglutide, dulaglutide and liraglutide ...